Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment

Jorma  Heikkonen; Hanna Mäenpää; Eero  Hippeläinen; Vappu Reijonen; Mikko Tenhunen

doi:10.1080/0284186X.2016.1182642

Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment

Jorma Heikkonen, Hanna Mäenpää, Eero Hippeläinen, Vappu Reijonen, Mikko Tenhunen

Research output: Contribution to journal › Review Article › peer-review

Original language	English
Journal	Acta Oncologica
Volume	55
Issue number	9-10
Pages (from-to)	1069-1076
Number of pages	8
ISSN	0284-186X
DOIs	https://doi.org/10.1080/0284186X.2016.1182642
Publication status	Published - 2016
MoE publication type	A2 Review article in a scientific journal

Fields of Science

RECEPTOR RADIONUCLIDE THERAPY
NEUROENDOCRINE TUMORS
INDIVIDUALIZED DOSIMETRY
FOLLOW-UP
OCTREOTATE
PATIENT
LU-177-DOTATATE
GUIDELINES
DIAGNOSIS
TOXICITY
3122 Cancers

Access to Document

10.1080/0284186X.2016.1182642

Cite this

@article{5d8dcfe97013421898bfcb9dfaa65076,

title = "Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment",

keywords = "RECEPTOR RADIONUCLIDE THERAPY, NEUROENDOCRINE TUMORS, INDIVIDUALIZED DOSIMETRY, FOLLOW-UP, OCTREOTATE, PATIENT, LU-177-DOTATATE, GUIDELINES, DIAGNOSIS, TOXICITY, 3122 Cancers",

author = "Jorma Heikkonen and Hanna M{\"a}enp{\"a}{\"a} and Eero Hippel{\"a}inen and Vappu Reijonen and Mikko Tenhunen",

year = "2016",

doi = "10.1080/0284186X.2016.1182642",

language = "English",

volume = "55",

pages = "1069--1076",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "9-10",

}

TY - JOUR

T1 - Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment

AU - Heikkonen, Jorma

AU - Mäenpää, Hanna

AU - Hippeläinen, Eero

AU - Reijonen, Vappu

AU - Tenhunen, Mikko

PY - 2016

Y1 - 2016

KW - RECEPTOR RADIONUCLIDE THERAPY

KW - NEUROENDOCRINE TUMORS

KW - INDIVIDUALIZED DOSIMETRY

KW - FOLLOW-UP

KW - OCTREOTATE

KW - PATIENT

KW - LU-177-DOTATATE

KW - GUIDELINES

KW - DIAGNOSIS

KW - TOXICITY

KW - 3122 Cancers

U2 - 10.1080/0284186X.2016.1182642

DO - 10.1080/0284186X.2016.1182642

M3 - Review Article

SN - 0284-186X

VL - 55

SP - 1069

EP - 1076

JO - Acta Oncologica

JF - Acta Oncologica

IS - 9-10

ER -